GBS Global Biopharma, Inc.

THE FUTURE OF HEALING

We are a dedicated plant-based research and biopharmaceutical drug development company. Our goal is to create patented formulations of plant-inspired, minimum essential mixtures for use as prescription medications.

Learn More

PARKINSON’S DISEASE
THERAPIES

We achieved statistically significant results in our Animal Proof-of-Concept Study, and the US Patent was issued in 2020. Our goal is to begin our First-in-Man trial as soon as possible.

Learn More

COVID-RELATED CYTOKINE RELEASE SYNDROME THERAPIES

In 2021, Gb Sciences achieved positive proof-of-concept results for therapies designed to suppress COVID-Related Hyperinflammation.

Learn More

PhAROS Drug Discovery Platform

Pharos uses AI technology to identify and predict the efficacy of combinations of novel active ingredients from plants.

Learn More

Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease

Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

Choose Your Area Of Interest

Research Partners

The strength of our R & D pipeline has been the participation of world class researchers from 9 international universities over the past 7 years. Together, we have assembled the ultimate toolkit to create the future of medicine; AI technology, plant-based medicine, and hard sciences.

Development Partners

Translating new drug principles into real world medicines requires expertise in several disciplines. Our partners help make our dream of novel plant-inspired medicines a reality by providing expertise in cGMP-certified active ingredients and novel oral delivery methods.

NEXT GENERATION
PLANT-INSPIRED MEDICINE

Our Goal is to preserve the efficacy of plant-based medicines while reducing their complexity for standardization.

Our Strategy is to combine our proprietary PhAROS Drug Discovery Platform and High Throughput Screening of Cell and Animal Models of Specific Disease Processes to Create Rationally-Designed, Minimum Essential Mixtures.

Latest News from GbS' Global Parent Company

Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease

Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

Choose Your Area Of Interest

Research Partners

The strength of our R & D pipeline has been the participation of world class researchers from 9 international universities over the past 7 years. Together, we have assembled the ultimate toolkit to create the future of medicine; AI technology, plant-based medicine, and hard sciences.

Development Partners

Translating new drug principles into real world medicines requires expertise in several disciplines. Our partners help make our dream of novel plant-inspired medicines a reality by providing expertise in cGMP-certified active ingredients and novel oral delivery methods.

NEXT GENERATION
PLANT-INSPIRED MEDICINE

Our Goal is to preserve the efficacy of plant-based medicines while reducing their complexity for standardization.

Our Strategy is to combine our proprietary PhAROS Drug Discovery Platform and High Throughput Screening of Cell and Animal Models of Specific Disease Processes to Create Rationally-Designed, Minimum Essential Mixtures.

Looking to learn more about Gb Sciences?

Learn about Gb Sciences' research developments, patents, and emerging drug discoveries by visiting our News Room.